Next 10 |
home / stock / bmrn / bmrn articles
Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.44% on an annualized basis producing an average annua...
Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.65% on an annualized basis producing an average annua...
Disclosed in a recent SEC filing on June 4, MEIER, Board Member at Biomarin Pharmaceutical (NASDAQ:BMRN), made a noteworthy transaction involving t...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Dennis Slamon, Board Member at Biomarin Pharmaceutical (NASDAQ:BMRN), reported a large exercise of company stock options on March 20, according to ...
HENRY FUCHS, President at Biomarin Pharmaceutical (NASDAQ:BMRN), reported an insider sell on March 7, according to a new SEC filing. What Happened...
Activist investor Elliott Investment Management has taken a significant position in BioMarin Pharmaceutical Inc (NASDAQ: BMRN),...
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today&...
In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a delay to the planned submission of sepiapterin in ph...
News, Short Squeeze, Breakout and More Instantly...
BioMarin Pharmaceutical Inc. Company Name:
BMRN Stock Symbol:
NASDAQ Market:
BioMarin Pharmaceutical Inc. Website:
2024-07-10 03:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-27 14:15:03 ET Scotiabank analyst issues UNDERPERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Underperform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-06-27 14:15:02 ET Wells Fargo analyst issues SECTOR PERFORM recommendation for BMRN on June 27, 2024 12:01PM ET. The previous analyst recommendation was Sector Perform. BMRN was trading at $82.885 at issue of the analyst recommendation. The overall analyst consensus...